Queensland’s growing biomedical sector is underpinned by internationally renowned excellence in scientific research and innovation. The state is home to more than 250 life sciences companies, 85 core biotech companies, and 80+ biotech-related research organisations
Queensland has world-leading research institutes and science capability, with unrivalled expertise in tropical and infectious diseases and vaccine development and delivery. Growth in the biomedical sector is supported by the $420 million Advance Queensland program.
Queensland is also a biodiversity hotspot, with unique opportunities to source solutions from nature.
A world leader in biomedicine
Queensland is recognised around the world for its biomedical research and development. QIMR Berghofer Medical Research Institute is among Australia’s leading medical research facilities, and the University of Queensland hosts globally recognised research and drug discovery institutes. James Cook University in North Queensland is home to the Australian Institute of Tropical Health and Medicine.
Queensland is also home to Australia’s only 2 facilities fully dedicated to the cGMP-grade contract manufacture of biopharmaceutical active ingredients. The state’s streamlined clinical trial processes provide unique support to biomedical product developers, within a first-world regulatory environment that is 100% aligned with international standards.
Queensland Government support
The Queensland Biomedical 10-Year Roadmap and Action Plan (PDF, 1.2MB) is supporting the development of a biomedical sector recognised for its world-leading excellence in innovation, skills and facilities. Significant government incentives are available to support the engagement of overseas partners with Queensland biomedical projects and businesses.
Learn more about Queensland Government support for biomedical businesses and investors.
TIQ helps investors and trade partners harness opportunities by opening doors to local industry, economic development organisations, and local and state government bodies.
To explore opportunities to invest in our thriving biomedical sector, contact us today.